145 related articles for article (PubMed ID: 37172779)
1. Yield of annual endometrial cancer surveillance in women with PTEN Hamartoma Tumor Syndrome.
Kwinten KJJ; Drissen MMCM; de Hullu JA; Vos JR; Hoogerbrugge N; van Altena AM
Eur J Med Genet; 2023 Jul; 66(7):104785. PubMed ID: 37172779
[TBL] [Abstract][Full Text] [Related]
2. The yield and effectiveness of breast cancer surveillance in women with PTEN Hamartoma Tumor Syndrome.
Hoxhaj A; Drissen MMCM; Vos JR; Bult P; Mann RM; Hoogerbrugge N
Cancer; 2022 Aug; 128(15):2883-2891. PubMed ID: 36533707
[TBL] [Abstract][Full Text] [Related]
3. PTEN hamartoma tumour syndrome: case report based on data from the Iranian hereditary colorectal cancer registry and literature review.
Rahmatinejad Z; Goshayeshi L; Bergquist R; Goshayeshi L; Golabpour A; Hoseini B
Diagn Pathol; 2023 Apr; 18(1):43. PubMed ID: 37016356
[TBL] [Abstract][Full Text] [Related]
4. The gynecological surveillance of women with Lynch syndrome in Sweden.
Tzortzatos G; Andersson E; Soller M; Askmalm MS; Zagoras T; Georgii-Hemming P; Lindblom A; Tham E; Mints M
Gynecol Oncol; 2015 Sep; 138(3):717-22. PubMed ID: 26177554
[TBL] [Abstract][Full Text] [Related]
5. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome.
Bubien V; Bonnet F; Brouste V; Hoppe S; Barouk-Simonet E; David A; Edery P; Bottani A; Layet V; Caron O; Gilbert-Dussardier B; Delnatte C; Dugast C; Fricker JP; Bonneau D; Sevenet N; Longy M; Caux F;
J Med Genet; 2013 Apr; 50(4):255-63. PubMed ID: 23335809
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Analysis of Cancer Risk in Children and Adults With Germline PTEN Variants.
Yehia L; Plitt G; Tushar AM; Joo J; Burke CA; Campbell SC; Heiden K; Jin J; Macaron C; Michener CM; Pederson HJ; Radhakrishnan K; Shin J; Tamburro J; Patil S; Eng C
JAMA Netw Open; 2023 Apr; 6(4):e239705. PubMed ID: 37093598
[TBL] [Abstract][Full Text] [Related]
7. Detection and yield of thyroid cancer surveillance in adults with PTEN hamartoma tumour syndrome.
Drissen MMCM; Vos JR; Netea-Maier RT; Gotthardt M; Hoogerbrugge N
Endocr Relat Cancer; 2023 Oct; 30(10):. PubMed ID: 37451289
[TBL] [Abstract][Full Text] [Related]
8. PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing?
Mester JL; Moore RA; Eng C
Oncologist; 2013; 18(10):1083-90. PubMed ID: 24037976
[TBL] [Abstract][Full Text] [Related]
9. Colonic manifestations of PTEN hamartoma tumor syndrome: case series and systematic review.
Stanich PP; Pilarski R; Rock J; Frankel WL; El-Dika S; Meyer MM
World J Gastroenterol; 2014 Feb; 20(7):1833-8. PubMed ID: 24587660
[TBL] [Abstract][Full Text] [Related]
10. PTEN Hamartoma Tumor Syndrome: A Case of Renal Cell Carcinoma in a Young Female.
Ramkumar RR; Murthy PB; Nguyen JK; McKenney J; Eng C; Campbell SC
Urology; 2021 Feb; 148():113-117. PubMed ID: 33227300
[TBL] [Abstract][Full Text] [Related]
11. PTEN hamartoma tumor syndromes in childhood: description of two cases and a proposal for follow-up protocol.
Piccione M; Fragapane T; Antona V; Giachino D; Cupido F; Corsello G
Am J Med Genet A; 2013 Nov; 161A(11):2902-8. PubMed ID: 24123798
[TBL] [Abstract][Full Text] [Related]
12. Development and Progression of Thyroid Disease in
Plitt G; Brewer T; Yehia L; Jin J; Shin J; Eng C
Thyroid; 2022 Sep; 32(9):1094-1100. PubMed ID: 35761794
[No Abstract] [Full Text] [Related]
13. Lifetime cancer risks in individuals with germline PTEN mutations.
Tan MH; Mester JL; Ngeow J; Rybicki LA; Orloff MS; Eng C
Clin Cancer Res; 2012 Jan; 18(2):400-7. PubMed ID: 22252256
[TBL] [Abstract][Full Text] [Related]
14. Red flags for early recognition of adult patients with PTEN Hamartoma Tumour Syndrome.
Drissen MMCM; Schieving JH; Schuurs-Hoeijmakers JHM; Vos JR; Hoogerbrugge N
Eur J Med Genet; 2021 Dec; 64(12):104364. PubMed ID: 34637944
[TBL] [Abstract][Full Text] [Related]
15. Head circumference in the clinical detection of PTEN hamartoma tumor syndrome in a clinic population at high-risk of breast cancer.
Shiovitz S; Everett J; Huang SC; Orloff MS; Eng C; Gruber SB
Breast Cancer Res Treat; 2010 Nov; 124(2):459-65. PubMed ID: 20349131
[TBL] [Abstract][Full Text] [Related]
16. PTEN hamartoma of soft tissue: a distinctive lesion in PTEN syndromes.
Kurek KC; Howard E; Tennant LB; Upton J; Alomari AI; Burrows PE; Chalache K; Harris DJ; Trenor CC; Eng C; Fishman SJ; Mulliken JB; Perez-Atayde AR; Kozakewich HP
Am J Surg Pathol; 2012 May; 36(5):671-87. PubMed ID: 22446940
[TBL] [Abstract][Full Text] [Related]
17. Increased prevalence of eosinophilic gastrointestinal disorders in pediatric PTEN hamartoma tumor syndromes.
Henderson CJ; Ngeow J; Collins MH; Martin LJ; Putnam PE; Abonia JP; Marsolo K; Eng C; Rothenberg ME
J Pediatr Gastroenterol Nutr; 2014 May; 58(5):553-60. PubMed ID: 24345843
[TBL] [Abstract][Full Text] [Related]
18. Endometrial cancer in an adolescent: a possible manifestation of Cowden syndrome.
Schmeler KM; Daniels MS; Brandt AC; Lu KH
Obstet Gynecol; 2009 Aug; 114(2 Pt 2):477-479. PubMed ID: 19622968
[TBL] [Abstract][Full Text] [Related]
19. Clinical Implications for Germline PTEN Spectrum Disorders.
Ngeow J; Sesock K; Eng C
Endocrinol Metab Clin North Am; 2017 Jun; 46(2):503-517. PubMed ID: 28476234
[TBL] [Abstract][Full Text] [Related]
20. Thyroid nodules and cancer in children with PTEN hamartoma tumor syndrome.
Smith JR; Marqusee E; Webb S; Nose V; Fishman SJ; Shamberger RC; Frates MC; Huang SA
J Clin Endocrinol Metab; 2011 Jan; 96(1):34-7. PubMed ID: 20962022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
